• Citer

Efficacy of vedolizumab for induction of clinical response and remission in patients with moderate to severe inflammatory bowel disease who failed at least two TNF antagonists

par De Vos, Martine;Van Gossum, Marc ;Macken, Elisabeth;Ferrante, Marc;Hindryckx, Pieter P.M.;Dewit, Olivier;Holvoet, Tom;Franchimont, Denis ;Dhooghe, Barbara;Vermeire, Séverine;Louis, Edouard;Mana, Fazia;Elewaut, Ann;Bossuyt, Peter;Baert, Filip;Reenaers, Catherine
Référence United European gastroenterology journal, 6, 3, page (439-445)
Publication Publié, 2018-04

Article révisé par les pairs

• Détails
• Contenu

Titre:	Efficacy of vedolizumab for induction of clinical response and remission in patients with moderate to severe inflammatory bowel disease who failed at least two TNF antagonists
Auteur:	De Vos, Martine; Van Gossum, Marc; Macken, Elisabeth; Ferrante, Marc; Hindryckx, Pieter P.M.; Dewit, Olivier; Holvoet, Tom; Franchimont, Denis; Dhooghe, Barbara; Vermeire, Séverine; Louis, Edouard; Mana, Fazia; Elewaut, Ann; Bossuyt, Peter; Baert, Filip; Reenaers, Catherine
Informations sur la publication:	United European gastroenterology journal, 6, 3, page (439-445)
Statut de publication:	Publié, 2018-04
Sujet CREF:	Généralités
Mots-clés:	inflammatory bowel disease
	observational study
	refractory patients
	Vedolizumab
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:2050-6406
	info:doi/10.1177/2050640617722310
	info:scp/85044403863